Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14651 - 14675 of 14774 in total
BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
Experimental
Investigational
Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Investigational
Ondelopran has been used in trials studying the treatment of Alcohol Dependence.
Investigational
Siagoside (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Siagoside completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to...
Investigational
Matched Description: … substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and
Displaying drugs 14651 - 14675 of 14774 in total